The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 19,222 | 3,914,938 | SH | SOLE | 3,914,938 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 7,178 | 1,161,466 | SH | SOLE | 1,161,466 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 69,882 | 5,801,748 | SH | SOLE | 5,801,748 | 0 | 0 | ||
| ANGION BIOMEDICA CORP | COM | 03476J107 | 2,737 | 280,183 | SH | SOLE | 280,183 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 8,264 | 912,125 | SH | SOLE | 912,125 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 961 | 264,100 | SH | SOLE | 264,100 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM | 05338F108 | 1,853 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 10,830 | 2,635,014 | SH | SOLE | 2,635,014 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 1,754 | 782,817 | SH | SOLE | 782,817 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 5,304 | 294,692 | SH | SOLE | 294,692 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 648 | 486,982 | SH | SOLE | 486,982 | 0 | 0 | ||
| CONTRAFECT CORP | COM NEW | 212326300 | 139 | 34,413 | SH | SOLE | 34,413 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 23,495 | 7,964,329 | SH | SOLE | 7,964,329 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 665 | 165,775 | SH | SOLE | 165,775 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 2,286 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 839 | 80,537 | SH | SOLE | 80,537 | 0 | 0 | ||
| GALAPAGOS NV-SPON ADR | SPONS ADR | 36315X101 | 12,848 | 244,205 | SH | SOLE | 244,205 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 6,759 | 1,724,201 | SH | SOLE | 1,724,201 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 198 | 22,409 | SH | SOLE | 22,409 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,490 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 3,728 | 410,535 | SH | SOLE | 410,535 | 0 | 0 | ||
| LEAP THERAPEUTICS INC | COM | 52187K101 | 1,003 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| NEUBASE THERAPEUTICS INC | COM | 64132K102 | 396 | 109,742 | SH | SOLE | 109,742 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 10,930 | 3,252,892 | SH | SOLE | 3,252,892 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 9,159 | 4,489,687 | SH | SOLE | 4,489,687 | 0 | 0 | ||
| SCYNEXIS INC | COM NEW | 811292200 | 34 | 6,327 | SH | SOLE | 6,327 | 0 | 0 | ||
| SEASPINE HOLDINGS CORP | COM | 81255T108 | 131 | 8,349 | SH | SOLE | 8,349 | 0 | 0 | ||
| SYNLOGIC INC | COM | 87166L100 | 3,050 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 5,313 | 390,637 | SH | SOLE | 390,637 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 1,696 | 68,542 | SH | SOLE | 68,542 | 0 | 0 | ||
| YUMANITY THERAPEUTICS INC | COM | 98872L102 | 4,971 | 481,692 | SH | SOLE | 481,692 | 0 | 0 | ||